CFTR Modulators: Impact on Fertility, Pregnancy, and Lactation in Women with Cystic Fibrosis
Open Access
- 21 August 2020
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (9), 2706
- https://doi.org/10.3390/jcm9092706
Abstract
Cystic fibrosis (CF) is a life-shortening genetic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. These mutations lead to abnormal ion transport in mucous membranes throughout the body, including in the respiratory and gastrointestinal and reproductive tracts. Improvements in care and therapy have led to substantial increases in the quantity and quality of life for those with CF. Consequently, women with CF are increasingly interested in having families. Although pregnancy was once discouraged for women with CF, at this point, even women with moderately severe lung disease can successfully navigate pregnancy. With the recent approval of a triple combination CFTR modulator therapy that improves lung function, nutritional status, and quality of life for people with a single copy of the most common CFTR mutation, it is expected that the number of women with CF who choose to become pregnant will continue to increase. Although animal reproduction models show no alarming signals for use during pregnancy at normal human doses, there is a paucity of human safety data in pregnancy and lactation. This review summarizes what is currently known about the impact of use of CFTR modulators on fertility, pregnancy, and lactation in women with CF.Funding Information
- Cystic Fibrosis (JAIN19A0, TAYLOR19Y3)
This publication has 40 references indexed in Scilit:
- Cystic fibrosis and fertilityCurrent Opinion in Obstetrics and Gynecology, 2013
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutationThe New England Journal of Medicine, 2011
- Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809Proceedings of the National Academy of Sciences of the United States of America, 2011
- Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTRMutationThe New England Journal of Medicine, 2010
- Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770Proceedings of the National Academy of Sciences of the United States of America, 2009
- Guidelines for the management of pregnancy in women with cystic fibrosisJournal of Cystic Fibrosis, 2008
- Cystic fibrosis and pregnancy. Report from French data (1980–1999)BJOG: An International Journal of Obstetrics and Gynaecology, 2002
- Outcome of pregnancy in women with cystic fibrosis.Thorax, 1995
- SIR FREDERICK TREVES AND THE ELEPHANT MANThe Lancet, 1980
- CYSTIC FIBROSIS OF THE PANCREAS AND ITS RELATION TO CELIAC DISEASEAmerican Journal of Diseases of Children, 1938